Your browser doesn't support javascript.
loading
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment.
Blinova, Ksenia; Dang, Qianyu; Millard, Daniel; Smith, Godfrey; Pierson, Jennifer; Guo, Liang; Brock, Mathew; Lu, Hua Rong; Kraushaar, Udo; Zeng, Haoyu; Shi, Hong; Zhang, Xiaoyu; Sawada, Kohei; Osada, Tomoharu; Kanda, Yasunari; Sekino, Yuko; Pang, Li; Feaster, Tromondae K; Kettenhofen, Ralf; Stockbridge, Norman; Strauss, David G; Gintant, Gary.
Afiliación
  • Blinova K; Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: ksenia.blinova@fda.hhs.gov.
  • Dang Q; Office of Biostatistics, Office of Translational Science, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Millard D; Axion BioSystems, Atlanta, GA 30309, USA.
  • Smith G; University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Clyde Biosciences, Newhouse ML1 5UH, Scotland, UK.
  • Pierson J; Health and Environmental Sciences Institute, Washington, DC 20005, USA.
  • Guo L; Investigative Toxicology, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD 21702, USA.
  • Brock M; Genentech, San Francisco, CA 94080, USA.
  • Lu HR; Discovery Sciences, R&D, Janssen Pharmaceutical (JNJ), Beerse, Belgium.
  • Kraushaar U; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Zeng H; Merck, Safety & Exploratory Pharmacology Department, West Point, PA 19486, USA.
  • Shi H; Bristol-Myers Squibb, New York, NY 10154, USA.
  • Zhang X; ACEA Biosciences, San Diego, CA 92121, USA.
  • Sawada K; Eisai, Tsukuba, Ibaraki 300-2635, Japan; The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Osada T; LSI Medience, Chiyoda-ku, Tokyo 101-8517, Japan.
  • Kanda Y; Division of Pharmacology, National Institute of Health Sciences, Kawasaki, Kanagawa 210-9501, Japan.
  • Sekino Y; The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan; Division of Pharmacology, National Institute of Health Sciences, Kawasaki, Kanagawa 210-9501, Japan.
  • Pang L; Division of Biochemical Toxicology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA.
  • Feaster TK; Cellular Dynamics International-A FUJIFILM Company, Madison, WI 53711, USA.
  • Kettenhofen R; Ncardia, Cologne 50829, Germany.
  • Stockbridge N; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Strauss DG; Division of Applied and Regulatory Science, Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Gintant G; AbbVie, North Chicago, IL 60064-6118, USA. Electronic address: gary.gintant@abbvie.com.
Cell Rep ; 24(13): 3582-3592, 2018 09 25.
Article en En | MEDLINE | ID: mdl-30257217

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Torsades de Pointes / Miocitos Cardíacos / Evaluación Preclínica de Medicamentos / Electrofisiología / Células Madre Pluripotentes Inducidas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Torsades de Pointes / Miocitos Cardíacos / Evaluación Preclínica de Medicamentos / Electrofisiología / Células Madre Pluripotentes Inducidas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2018 Tipo del documento: Article
...